Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.02136
European Journal of Endocrinology, Vol 154, Issue 5, 633-637
Copyright © 2006 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brabant, G
Right arrow Articles by Wiersinga, W M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brabant, G
Right arrow Articles by Wiersinga, W M

ARTICLE

Is there a need to redefine the upper normal limit of TSH?

G Brabant, P Beck-Peccoz1, B Jarzab2, P Laurberg3, J Orgiazzi4, I Szabolcs5, A P Weetman6 and W M Wiersinga7

Abteilung Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule, Hannover, Germany, 1 Institute of Endocrine Sciences, University of Milan, Ospedale Maggiore IRCCS, Padiglione Granelli, 20122-Milan, Italy, 2 Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland, 3 Department of Endocrinology and Medicine, Aalborg Hospital, Aarhus University Hospital, DK-9000 Aalborg, Denmark, 4 Service d’Endocrinologie Diabetologie, Centre Hospitalier Lyon Sud, Lyon, France, 5 Department of Internal Medicine, National Medical Center and Department of Dietetics, Semmelweis University, Budapest, Hungary, 6 Clinical Sciences Centre, Northern General Hospital, University of Sheffield, Sheffield, UK and 7 Academisch Medisch Centrum, Universiteit van Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands

(Correspondence should be addressed to G Brabant; Email: georg.brabant{at}manchester.ac.uk)

Abstract

Mild forms of hypothyroidism – subclinical hypothyroidism – have recently been discussed as being a risk factor for the development of overt thyroid dysfunction and for a number of clinical disorders. The diagnosis critically depends on the definition of the upper normal limit of serum TSH as, by definition, free thyroxine serum concentrations are normal. Cut-off levels of 4–5 mU TSH/l have been conventionally used to diagnose an elevated TSH serum concentration. Recent data from large population studies have suggested a much lower TSH cut-off with an upper limit of 2–2.5 mU/l but application of strict criteria for inclusion of subjects from the general population studies aiming at assessing TSH reference intervals (no personal or family history of thyroid disease, no thyroid antibodies and a normal thyroid on ultrasonography) did not result in an unequivocal upper limit of normal TSH at 2.0–2.5 mU/l. When summarizing the available evidence for lowered upper TSH cut-off values and their potential therapeutic implications there is presently insufficient justification to lower the upper normal limit of TSH and, for practical purposes, it is still recommended to maintain the TSH reference interval of 0.4–4.0 mU/l. Classifying subjects with a TSH value between 2 and 4 mU/l as abnormal, as well as intervening with thyroxine treatment in such subjects, is probably doing more harm than good.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
B. Biondi and D. S. Cooper
The Clinical Significance of Subclinical Thyroid Dysfunction
Endocr. Rev., February 1, 2008; 29(1): 76 - 131.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. I. Surks and J. G. Hollowell
Age-Specific Distribution of Serum Thyrotropin and Antithyroid Antibodies in the U.S. Population: Implications for the Prevalence of Subclinical Hypothyroidism
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4575 - 4582.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J. Girling and C. Nelson-Piercy
Three unresolved issues
BMJ, August 25, 2007; 335(7616): 362 - 362.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
E. Jensen, O. Blaabjerg, P. H. Petersen, and L. Hegedus
Sampling Time Is Important but May Be Overlooked in Establishment and Use of Thyroid-Stimulating Hormone Reference Intervals
Clin. Chem., February 1, 2007; 53(2): 355 - 356.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 European Society of Endocrinology.